Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Teleoanalysis: combining data from different types of study.

Wald NJ, Morris JK.

BMJ. 2003 Sep 13;327(7415):616-8. Review. No abstract available.

2.

Theoretical and methodological differentiation of moderation and mediation.

Lindley P, Walker SN.

Nurs Res. 1993 Sep-Oct;42(5):276-9. No abstract available.

PMID:
8415040
3.

Analysing and interpreting competing risk data.

Pintilie M.

Stat Med. 2007 Mar 15;26(6):1360-7.

PMID:
16900575
4.

An overview of relations among causal modelling methods.

Greenland S, Brumback B.

Int J Epidemiol. 2002 Oct;31(5):1030-7. Review.

PMID:
12435780
5.

Estimation of distribution function in bivariate competing risk models.

Sankaran PG, Lawless JF, Abraham B, Antony AA.

Biom J. 2006 Jun;48(3):399-410.

PMID:
16845904
6.

[Interpretation of an epidemiolog survey. Survey types, concepts of bias, causality].

Landais P, Jais JP.

Rev Prat. 1992 Nov 15;42(18):2377-82. French. No abstract available.

PMID:
1296310
7.

[Interpretation of an epidemiological survey. Survey types, concepts of bias, causality].

Bastuji-Garin S.

Rev Prat. 1996 Apr 15;46(8):997-1003. French. No abstract available.

PMID:
8762237
8.

Environment and health: 9. The science of risk assessment.

Bailar JC 3rd, Bailer AJ.

CMAJ. 2001 Feb 20;164(4):503-6. Review. No abstract available.

10.

[Applying a directed acyclic graph (DAG): testosterone as a risk factor for development of type 2 diabetes mellitus in the study of health in Pomerania (SHIP)].

Schipf S.

Gesundheitswesen. 2011 Dec;73(12):906-8. doi: 10.1055/s-0031-1291193. Epub 2011 Dec 22. German. No abstract available.

PMID:
22193903
11.

[Causal graph (directed acyclic graph - DAG) of a secondary data analysis regarding sickness absence due to musculoskeletal disorders].

Liebers F, Brendler C, Latza U.

Gesundheitswesen. 2011 Dec;73(12):918-20. doi: 10.1055/s-0031-1291191. Epub 2011 Dec 22. German. No abstract available.

PMID:
22193907
12.

[Causality in epidemiology: populations, individuals, and alternative explanations].

Botti C, Comba P, Pirastu R, Vineis P.

Epidemiol Prev. 1999 Oct-Dec;23(4):260-7. Italian.

PMID:
10730466
13.
14.

Identifiability of causal effects for binary variables with baseline data missing due to death.

Yan W, Hu Y, Geng Z.

Biometrics. 2012 Mar;68(1):121-8. doi: 10.1111/j.1541-0420.2011.01653.x. Epub 2011 Aug 12.

PMID:
21838813
15.
16.

Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases.

Fourrier A, Bégaud B, Alpérovitch A, Verdier-Taillefer MH, Touzé E, Decker N, Imbs JL.

Br J Clin Pharmacol. 2001 May;51(5):489-90. No abstract available.

17.

[What is epidemiology?].

du Prel JB, Röhrig B, Weinmayr G.

Klin Monbl Augenheilkd. 2010 Nov;227(11):R157-70; quiz R171-2. doi: 10.1055/s-0030-1250555. Epub 2010 Nov 12. German. No abstract available.

PMID:
21077012
18.

Using health care Failure Mode and Effect Analysis: the VA National Center for Patient Safety's prospective risk analysis system.

DeRosier J, Stalhandske E, Bagian JP, Nudell T.

Jt Comm J Qual Improv. 2002 May;28(5):248-67, 209.

PMID:
12053459
19.

Estimating the proportion of disease due to classes of sufficient causes.

Hoffmann K, Heidemann C, Weikert C, Schulze MB, Boeing H.

Am J Epidemiol. 2006 Jan 1;163(1):76-83. Epub 2005 Nov 17.

PMID:
16293718
20.

[Repeated measures analysis].

Ruiz de Villa Mdel C.

Med Clin (Barc). 2004;122 Suppl 1:51-8. Review. Spanish.

PMID:
14980161

Supplemental Content

Support Center